|
|
| |
| |
|
 |
Accomplishing Our Mission :
We will build relationships. We will strive to first understand the client needs, timelines and problems. We will develop effective means of communication while acting as a critical extension of our client’s team.
We will provide a broad range of services and capabilities:
 |
Specific preclinical anti-infective and anti-cancer drug and vaccine discovery/development service |
| |
|
 |
Basic research initiatives in microbiology, molecular biology, immunology,
biochemistry, cell biology, and in vitro and immunotoxicology. |
|
| |
We will provide a multidisciplinary approach to scientific research:
 |
Rapid development of technology and novel assays in support the of client’s
therapeutic development program. |
| |
|
 |
Use of state of the art technologies and approaches to provide the most effective
solutions in the shortest time. |
|
| |
 |
| |
| Scientific Team: |
Robert W. Buckheit, Jr., Ph.D. President and Chief Scientific Officer
Todd Parsley, Ph.D., Molecular Biology Services
Dwayne Lunsford, Ph.D., Anti-Microbial Services
Tracy Hartman, M.S., Anti-Infective Services
Karen Watson, M.S., Topical Microbicide Services
Lu Yang, MD., Anti-Infective Services |
|
 |
|
 |
|
|
|
|
| |
| |
| Copyright © 2006, ImQuest BioSciences. | | | |
| | | | | |
| | | | |
| |
|
|